Maplight Therapeutics, Inc. · NASDAQ:MPLT
Kreitzer Anatol sold 45,422 Maplight Therapeutics, Inc. shares (Form 4)
Traded Apr 27, 2026 · Filed Apr 29, 2026
On Apr 27, 2026, Kreitzer Anatol (Chief Discovery Officer) sold 45,422 Maplight Therapeutics, Inc. shares at an average US$29.66 for US$1.35M under a trading plan, leaving 211,190 shares. Filed Apr 29, 2026 (Form 4).
- Sold
- 45,422 shares
- Price
- US$29.66 average (US$28.96 to US$30.50)
- Value
- US$1.35M
- Holding after
- 211,190 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Discovery Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 27, 2026 | Voting Common Stock | Sale | 8,346 | US$28.96 | 248,266 | Direct |
| Apr 27, 2026 | Voting Common Stock | Sale | 29,255 | US$29.63 | 219,011 | Direct |
| Apr 27, 2026 | Voting Common Stock | Sale | 7,821 | US$30.50 | 211,190 | Direct |
Source
Related
- Maplight Therapeutics, Inc.
- Kreitzer Anatol
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Kreitzer Anatol · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Aug 19, 2026
- Form 4 · Kreitzer Anatol · Jul 20, 2026
- Form 4 · Kreitzer Anatol · Apr 17, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Lillie James Woodruff · Oct 16, 2026